Skip to main content
Dynavax Technologies Corporation (LON:0IDA)
London flag London · Delayed Price · Currency is GBP · Price in USD
11.60
+0.33 (2.93%)
At close: Apr 30, 2025

Dynavax Technologies Revenue

In the year 2024, Dynavax Technologies had annual revenue of $277.25M USD with 19.36% growth. Dynavax Technologies had revenue of $72.03M in the quarter ending December 31, 2024, with 29.56% growth.

Revenue
$277.25M
Revenue Growth
+19.36%
P/S Ratio
4.87
Revenue / Employee
$684.56K
Employees
405
Market Cap
1.08B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024277.25M44.96M19.36%
Dec 31, 2023232.28M-490.40M-67.86%
Dec 31, 2022722.68M283.24M64.45%
Dec 31, 2021439.44M399.19M991.75%
Dec 31, 202040.25M5.03M14.29%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.38B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Oxford Nanopore Technologies 183.19M
Revenue Rankings

Dynavax Technologies News

More News